PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
31-Jul-2024 New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders  University of Oxford
31-Jul-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
31-Jul-2024 Galen announces exclusive licensing agreement with Italfarmaco for the distribution of Cariban® (doxylamine/pyridoxine) in Ireland for nausea and vomiting in pregnancy Galen Ltd
25-Jul-2024 Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience Eisai Inc
25-Jul-2024 4D Medicine raises £3.4m for unique biomaterial platform 4D Medicine
25-Jul-2024 Early onset dementia more common than previously reported – the incidence of Alzheimer’s disease seems to be on the rise University of Eastern Finland
25-Jul-2024 Almac Pharma Services Announces Successful FDA Inspection at Charnwood, UK Facilities Almac Pharma Services
24-Jul-2024 New Facility Assures Continuity of Supply of Anti-Obesity Treatment CONTRAVE®/MYSIMBA® Amidst GLP-1 Supply Issues Currax Pharmaceuticals LLC
24-Jul-2024 SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLP01 Targeting Human Cytomegalovirus (HCMV) SpyBiotech
23-Jul-2024 Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial PureTech Health
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
23-Jul-2024 ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy for maintenance therapy of HIV-1 ViiV Healthcare
23-Jul-2024 ViiV Healthcare announces positive new data for Apretude use during pregnancy at AIDS 2024 ViiV Healthcare
23-Jul-2024 ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor AIDS 2024 ViiV Healthcare
23-Jul-2024 New rapid method for determining virus infectivity University of Birmingham
23-Jul-2024 Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs Xeltis
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
22-Jul-2024 Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals Avista Capital Partners
22-Jul-2024 Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024 Transgene
22-Jul-2024 Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis Certa Therapeutics